1. Huang GJ, Stein JP. Open radical cystectomy with lymphadenectomy remains the treatment of choice for invasive bladder cancer. Curr Opin Urol. 2007. 17:369–375.
2. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol. 2002. 167:1295–1298.
3. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol. 2003. 169:946–950.
4. Leissner J, Hohenfellner R, Thüroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int. 2000. 85:817–823.
5. Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003. 170:35–41.
6. Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol. 2008. 179:873–878.
7. Guru KA, Sternberg K, Wilding GE, Tan W, Butt ZM, Mohler JL, et al. The lymph node yield during robot-assisted radical cystectomy. BJU Int. 2008. 102:231–234.
8. Ghazi A, Zimmermann R, Al-Bodour A, Shefler A, Janetschek G. Optimizing the approach for lymph node dissection during laparoscopic radical cystectomy. Eur Urol. 2010. 57:71–78.
9. Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol. 1998. 160(6 Pt 1):2015–2019.
10. Brössner C, Pycha A, Toth A, Mian C, Kuber W. Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int. 2004. 93:64–66.
11. Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, Sarosdy MF, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004. 22:2781–2789.
12. Dangle PP, Gong MC, Bahnson RR, Pohar KS. How do commonly performed lymphadenectomy templates influence bladder cancer nodal stage? J Urol. 2010. 183:499–503.
13. Adsan O, Baltaci S, Cal C, Buyukalpelli R, Ugurlu O, Bozlu M, et al. Reliability of frozen section examination of external iliac, hypogastric, and obturator lymph nodes during radical cystectomy: a multicenter study. Urology. 2007. 69:83–86.
14. Baltaci S, Adsan O, Ugurlu O, Aslan G, Can C, Gunaydin G, et al. Reliability of frozen section examination of obturator lymph nodes and impact on lymph node dissection borders during radical cystectomy: results of a prospective multicentre study by the Turkish Society of Urooncology. BJU Int. 2011. 107:547–553.
15. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J Urol. 2003. 169:943–945.
16. Wiesner C, Salzer A, Thomas C, Gellermann-Schultes C, Gillitzer R, Hampel C, et al. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. BJU Int. 2009. 104:331–335.
17. Stein JP, Penson DF, Cai J, Miranda G, Skinner EC, Dunn MA, et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol. 2007. 177:876–881.
18. Bochner BH, Herr HW, Reuter VE. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol. 2001. 166:2295–2296.
19. Leissner J, Ghoneim MA, Abol-Enein H, Thuroff JW, Franzaring L, Fisch M, et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol. 2004. 171:139–144.
20. Epstein JI, Amin MB, Reuter VR, Mostofi FK. Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol. 1998. 22:1435–1448.
21. Sobin LH, Wittekind C. TNM classification of malignant tumours. 2002. 6th ed. New York: Wiley-Liss.
22. Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001. 19:666–675.
23. Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol. 2006. 176:2414–2422.
24. Dorin RP, Skinner EC. Extended lymphadenectomy in bladder cancer. Curr Opin Urol. 2010. 20:414–420.
25. Holmer M, Bendahl PO, Davidsson T, Gudjonsson S, Mansson W, Liedberg F. Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference? World J Urol. 2009. 27:521–526.
26. Karl A, Carroll PR, Gschwend JE, Knuchel R, Montorsi F, Stief CG, et al. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol. 2009. 55:826–835.
27. Fleischmann A, Thalmann GN, Markwalder R, Studer UE. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol. 2005. 23:2358–2365.
28. Studer UE, Collette L. Morbidity from pelvic lymphadenectomy in men undergoing radical prostatectomy. Eur Urol. 2006. 50:887–889.